Canine 1-DAPPv
A proven foundation for vaccine protocols. Canine 1-DAPPv is a combination vaccine approved for protection against canine distemper virus, adenovirus type 1 and 2, canine parainfluenza virus, and canine parvovirus.
- Protects against all known strains of CPV, including CPV-2c2,3
- High antigenic mass (titer), low passage parvovirus vaccine
- Canine vaccine containing CPV-2b, one of the most prevalent field strains of parvovirus
- Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
- Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus in 1 formula
- First to publish data showing protection against CPV-2c challenge2
- Multiple studies demonstrate the ability to override maternal antibodies1
NOBIVAC® CANINE 1-DAPPv PROVIDES PROTECTION AGAINST:
Canine Distemper Virus, Canine Adenovirus type 1, Canine Adenovirus type 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses).
INDICATIONS:
Shown to be effective for the vaccination against canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus and canine parvovirus.
ADMINISTRATION AND DOSAGE
- Subcutaneous or intramuscular injection
- Primary vaccination may begin as early as 6 weeks
- Repeat dose at 2 to 4 weeks later.
- Two doses are required for primary immunization.
- Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For more information on revaccination frequency, in general or in the face of maternal antibody, consult your veterinarian or the manufacturer.
- Available in a 25 x 1 mL dose presentation
